Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026)
Beam Therapeutics (BEAM) reported Prepaid Assets of $55.3 million for Q1 2026, up 99.92% year-over-year from $27.7 million in Q1 2025, and up 135.54% on a QoQ basis from $23.5 million in Q4 2025.
Beam Therapeutics (BEAM) has 8 years of Prepaid Assets data on file, last reported at $55.3 million in Q1 2026.
- Quarterly Prepaid Assets rose 99.92% year-over-year to $55.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $55.3 million (up 99.92% YoY) and the FY2025 annual result came in at $23.5 million, down 14.34% from the prior year.
- Prepaid Assets improved to $55.3 million in Q1 2026 per BEAM's latest filing, from $23.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $55.3 million in Q1 2026 and bottomed at $13.8 million in Q2 2022.
- The 5-year median for Prepaid Assets is $23.5 million (2025), against an average of $23.6 million.
- The widest annual swing landed in 2022, when Prepaid Assets surged 100.57%; it then slipped 17.88% in 2024.
- Tracing BEAM's Prepaid Assets over 5 years: stood at $14.8 million in 2022, then jumped by 43.39% to $21.2 million in 2023, then gained by 29.49% to $27.4 million in 2024, then dropped by 14.34% to $23.5 million in 2025, then surged by 135.54% to $55.3 million in 2026.
- Per Business Quant, the three latest BEAM Prepaid Assets figures stand at $55.3 million (Q1 2026), $23.5 million (Q4 2025), and $23.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Beam Therapeutics | 3.40 Bn | 3.40 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.30 Mn |
| Dec 31, 2025 | 23.48 Mn |
| Sep 30, 2025 | 23.58 Mn |
| Jun 30, 2025 | 25.13 Mn |
| Mar 31, 2025 | 27.66 Mn |
| Dec 31, 2024 | 27.41 Mn |
| Sep 30, 2024 | 19.78 Mn |
| Jun 30, 2024 | 21.28 Mn |
| Mar 31, 2024 | 27.16 Mn |
| Dec 31, 2023 | 21.17 Mn |
| Sep 30, 2023 | 24.08 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 23.56 Mn |
| Dec 31, 2022 | 14.76 Mn |
| Sep 30, 2022 | 14.36 Mn |
| Jun 30, 2022 | 13.78 Mn |
| Mar 31, 2022 | 16.88 Mn |
| Dec 31, 2021 | 7.36 Mn |
| Sep 30, 2021 | 8.02 Mn |
| Jun 30, 2021 | 12.71 Mn |
| Mar 31, 2021 | 11.10 Mn |
| Dec 31, 2020 | 8.65 Mn |
| Sep 30, 2020 | 6.49 Mn |
| Jun 30, 2020 | 6.88 Mn |
| Mar 31, 2020 | 6.19 Mn |
| Dec 31, 2019 | 2.70 Mn |